CannaBlogCanna~Fangled AbstractsFor Your Consideration... The ECS and Cannabinoids in Liver Disease Treatment Cannabinoids and Liver Diseases: The Role of Endocannabinoids in Healing and Treatment This blog explores…Freedom WaresApril 28, 2025
Canna~Fangled Abstracts Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock? Cannabis and Cannabinoid ResearchAhead of PrintOpen AccessCreative Commons license Tangui Barré, Vincenzo Di Marzo, Fabienne…Freedom WaresApril 12, 2022
Canna~Fangled Abstracts Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 19:109677. doi: 10.1016/j.pnpbp.2019.109677. Vázquez-Bourgon J1, de la Foz VO2,…Freedom WaresJune 19, 2019
Canna~Fangled Abstracts Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH). J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12797. Nordmann S1,2, Vilotitch A1,2, Roux P1,2, Esterle…Freedom WaresOctober 6, 2017
Canna~Fangled Abstracts Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8. Wang Y1,2, Mukhopadhyay P1, Cao Z1, Wang H3,…Freedom WaresSeptember 21, 2017
Canna~Fangled Abstracts [A role for the endocannabinoid system in hepatic steatosis]. 2014 Mar;142(3):353-60. doi: 10.4067/S0034-98872014000300010. . Valenzuela C, Castillo V, Ronco AM, Aguirre C, Hirsch S, Llanos M. Abstract The endocannabinoid…Freedom WaresMarch 14, 2014